Finance
Vitex reports fourth quarter and year-end 2001 losses
Published in Blood Weekly, April 18th, 2002
For the fourth quarter, V.I. Technologies Inc. (Vitex) reported a net loss of $1.9 million, or $0.08 per share, compared with $4.7 million, or $0.23 per share, for the fourth quarter of 2000. The fourth quarter loss includes a $2.0 million credit equal to $0.09 per share for the previously announced contingent payment from Precision Pharma Services Inc. Excluding this credit, the company lost $3.9 million, or $0.17 per share, in the fourth quarter.
For the year-ended December 29, 2001, the net loss was $23.4 million, or $1.05 per share, compared...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2002-04-18)
More Articles from Blood Weekly
- Hematology
Thalassemia treatment through globin gene transfer shows promise - Septicemia
Antithrombin reduces inflammatory cytokine output - Bone Marrow Transplantation
Short tandem repeats suitable for genetic engraftment tests - Stem Cell Transplantation
Megakaryocyte progenitor expansion feasible - Stem Cell Transplantation
No long-term risk of telomere shortening seen - Acute Care
High turnover rate may undermine HIV/hemophilia care - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
